
0:00
22:58
Plasma cell dyscrasia-driven hypercalcemia stems from uncoupled bone remodeling via RANKL upregulation, MIP-1alpha, and osteoclast activation rather than PTHrP mediation. We break down the diagnostic pathway distinguishing multiple myeloma from rare paraneoplastic causes, serum and urine protein electrophoresis, free light chain kinetics, and urgent therapeutic interventions using aggressive volume expansion, zoledronic acid, denosumab, and targeted clone-directed antimyeloma therapy.
More episodes from "Endocrine Deep Dives"



Don't miss an episode of “Endocrine Deep Dives” and subscribe to it in the GetPodcast app.








